Indeed, FOXD3-AS1 was shown to be downregulated in neuroblastoma tissues and NB-1643, SK-N-BE (2), NB-1691, IMR32, and BE (2)-C cells, and was regarded as an independent biomarker for a favorable prognosis (41). Here, FOXD3 is linked to neuroblastoma.